BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37318626)

  • 1. Targeting prostate cancer with docetaxel-loaded peptide 563-conjugated PEtOx-co-PEI
    Nezir AE; Bolat ZB; Ozturk N; Kocak P; Zemheri E; Gulyuz S; Ozkose UU; Yilmaz O; Vural I; Bozkır A; Sahin F; Telci D
    Amino Acids; 2023 Aug; 55(8):1023-1037. PubMed ID: 37318626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved anti-tumor efficiency against prostate cancer by docetaxel-loaded PEG-PCL micelles.
    Jin MJ; Piao SJ; Jin TX; Jin ZH; Yin XZ; Gao ZG
    J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):66-75. PubMed ID: 24496681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.
    Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Mirsafaei R
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1139-1157. PubMed ID: 29436875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA.
    Kang Y; Lu L; Lan J; Ding Y; Yang J; Zhang Y; Zhao Y; Zhang T; Ho RJY
    Acta Biomater; 2018 Mar; 68():137-153. PubMed ID: 29288085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
    Ostacolo L; Marra M; Ungaro F; Zappavigna S; Maglio G; Quaglia F; Abbruzzese A; Caraglia M
    J Control Release; 2010 Dec; 148(2):255-63. PubMed ID: 20816710
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Kazemi M; Emami J; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A; Mokhtari M
    Recent Pat Anticancer Drug Discov; 2020; 15(4):341-359. PubMed ID: 33023456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of taxane-binding peptide-modified polymeric micelles loaded with docetaxel in an orthotopic breast cancer mouse model.
    Logie J; Ganesh AN; Aman AM; Al-Awar RS; Shoichet MS
    Biomaterials; 2017 Apr; 123():39-47. PubMed ID: 28161682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox-sensitive micelles assembled from amphiphilic mPEG-PCL-SS-DTX conjugates for the delivery of docetaxel.
    Zhang H; Wang K; Zhang P; He W; Song A; Luan Y
    Colloids Surf B Biointerfaces; 2016 Jun; 142():89-97. PubMed ID: 26938324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide-modified polymeric micelles as potential carriers for targeted docetaxel delivery to somatostatin receptor overexpressing tumor cells.
    Zhang Y; Wang X; Wang J; Zhang X; Zhang Q
    Pharm Res; 2011 May; 28(5):1167-78. PubMed ID: 21340573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel-loaded pluronic p123 polymeric micelles: in vitro and in vivo evaluation.
    Liu Z; Liu D; Wang L; Zhang J; Zhang N
    Int J Mol Sci; 2011; 12(3):1684-96. PubMed ID: 21673916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spacer length impacts the efficacy of targeted docetaxel conjugates in prostate-specific membrane antigen expressing prostate cancer.
    Peng ZH; Sima M; Salama ME; Kopečková P; Kopeček J
    J Drug Target; 2013 Dec; 21(10):968-80. PubMed ID: 24160903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
    Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L
    Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of docetaxel and chloroquine via PEO-PPO-PCL/TPGS micelles for overcoming multidrug resistance.
    Shi C; Zhang Z; Shi J; Wang F; Luan Y
    Int J Pharm; 2015 Nov; 495(2):932-9. PubMed ID: 26456262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivo.
    Harada M; Iwata C; Saito H; Ishii K; Hayashi T; Yashiro M; Hirakawa K; Miyazono K; Kato Y; Kano MR
    Int J Nanomedicine; 2012; 7():2713-27. PubMed ID: 22745540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
    Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
    Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSMA ligand conjugated PCL-PEG polymeric micelles targeted to prostate cancer cells.
    Jin J; Sui B; Gou J; Liu J; Tang X; Xu H; Zhang Y; Jin X
    PLoS One; 2014; 9(11):e112200. PubMed ID: 25386942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles containing chemically conjugated and physically entrapped docetaxel: synthesis, characterization, and the influence of the drug on micelle morphology.
    Mikhail AS; Allen C
    Biomacromolecules; 2010 May; 11(5):1273-80. PubMed ID: 20369884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro evaluation of a pH-sensitive PLA-PEG-folate based polymeric micelle for controlled delivery of docetaxel.
    Hami Z; Amini M; Ghazi-Khansari M; Rezayat SM; Gilani K
    Colloids Surf B Biointerfaces; 2014 Apr; 116():309-17. PubMed ID: 24503352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity.
    Dong Z; Wang Y; Guo J; Tian C; Pan W; Wang H; Yan J
    Drug Des Devel Ther; 2022; 16():2683-2693. PubMed ID: 35983428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy.
    Barve A; Jain A; Liu H; Zhao Z; Cheng K
    Acta Biomater; 2020 Sep; 113():501-511. PubMed ID: 32562805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.